Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological Malignancies

Frank Cichocki

doi:10.1016/j.jtct.2021.01.012

Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological Malignancies

Frank Cichocki

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	101-102
Number of pages	2
Journal	Transplantation and Cellular Therapy
Volume	27
Issue number	2
DOIs	https://doi.org/10.1016/j.jtct.2021.01.012
State	Published - Feb 2021

Bibliographical note

Funding Information:
Financial disclosure: The author has nothing to disclose. Conflict of interest statement: There are no conflicts of interest to report. Financial disclosure: See Acknowledgments on page 102.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.jtct.2021.01.012

OpenUrl availability

Full text

Cite this

@article{ce278789ab1e4532b9e504c2275adb5d,

title = "Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological Malignancies",

author = "Frank Cichocki",

note = "Funding Information: Financial disclosure: The author has nothing to disclose. Conflict of interest statement: There are no conflicts of interest to report. Financial disclosure: See Acknowledgments on page 102.",

year = "2021",

month = feb,

doi = "10.1016/j.jtct.2021.01.012",

language = "English (US)",

volume = "27",

pages = "101--102",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6367",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological Malignancies

AU - Cichocki, Frank

N1 - Funding Information: Financial disclosure: The author has nothing to disclose. Conflict of interest statement: There are no conflicts of interest to report. Financial disclosure: See Acknowledgments on page 102.

PY - 2021/2

Y1 - 2021/2

UR - http://www.scopus.com/inward/record.url?scp=85101138071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101138071&partnerID=8YFLogxK

U2 - 10.1016/j.jtct.2021.01.012

DO - 10.1016/j.jtct.2021.01.012

M3 - Comment/debate

C2 - 33781543

AN - SCOPUS:85101138071

SN - 2666-6367

VL - 27

SP - 101

EP - 102

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 2

ER -

Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological Malignancies

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this